Content about pharmaceutical

June 4, 2013

The Center for Healthcare Supply Chain Research, HDMA’s nonprofit research foundation, and Genentech on Tuesday honored Robert Belknap, executive director of trade sales and operations for Boehringer Ingelheim Pharmaceuticals, with the 2013 Nexus Award for Lifetime Achievement.

ARLINGTON, Va. — The Center for Healthcare Supply Chain Research, HDMA’s nonprofit research foundation, and Genentech on Tuesday honored Robert Belknap, executive director of trade sales and operations for Boehringer Ingelheim Pharmaceuticals, with the 2013 Nexus Award for Lifetime Achievement.

June 4, 2013

At the 2013 Business and Leadership Conference in Orlando, Fla., HDMA honored pharmaceutical and consumer product manufacturers during the presentation of the 2013 Distribution Industry Awards for Notable Achievements in Healthcare.

ARLINGTON, Va. — At the 2013 Business and Leadership Conference in Orlando, Fla., Tuesday, HDMA honored pharmaceutical and consumer product manufacturers during the presentation of the 2013 Distribution Industry Awards for Notable Achievements in Healthcare. 

June 4, 2013

The House of Representatives voted Monday to pass a bill that would establish national standards for the pharmaceutical supply chain.

WASHINGTON — The House of Representatives voted Monday to pass a bill that would establish national standards for the pharmaceutical supply chain.

June 3, 2013

AmerisourceBergen announced that it has completed the divestiture of its Canadian pharmaceutical distribution business, AmerisourceBergen Canada Corp.

VALLEY FORGE, Pa. — AmerisourceBergen on Monday announced that it has completed the divestiture of its Canadian pharmaceutical distribution business, AmerisourceBergen Canada Corporation. As previously announced, the business has been sold to Kohl & Frisch Limited, a Canadian-owned national full-line distributor. 

AmerisourceBergen will retain its Canadian specialty business.

June 3, 2013

Efforts to create a generic top-level domain for legitimate pharmacy websites gained traction last week when the Internet Corporation for Assigned Names and Numbers, or ICANN - the body that controls what goes into Internet URLs - gave the National Association of Boards of Pharmacy a passing grade for an initial evaluation of its plans for the domain, ".pharmacy."

If successful, the .pharmacy domain will create a powerful new weapon to combat the rise of illegal online pharmacies, which, according to many studies, constitute all but 3% of the websites selling drugs on the Internet. These are the "Canadian" pharmacies selling cheap drugs that one often sees links to on search engines and other websites; despite their supposed provenance, they're usually based in countries where regulations are lax or unenforced.

Efforts to create a generic top-level domain for legitimate pharmacy websites gained traction last week when the Internet Corporation for Assigned Names and Numbers, or ICANN — the body that controls what goes into Internet URLs — gave the National Association of Boards of Pharmacy a passing grade for an initial evaluation of its plans for the domain ".pharmacy."

May 30, 2013

Beauty trends are as much a reflection of the consumer's state of mind as they are a reflection of the technological innovations put forth by research-and-development teams at laboratories around the world. While consumers are not able to verbalize their expectations for the ideal product that will fulfill their needs, they are able to pinpoint gaps with their unmet needs through their purchasing patterns.

GUEST COLUMN BY DANIELA CIOCAN

Beauty trends are as much a reflection of the consumer's state of mind as they are a reflection of the technological innovations put forth by research-and-development teams at laboratories around the world. While consumers are not able to verbalize their expectations for the ideal product that will fulfill their needs, they are able to pinpoint gaps with their unmet needs through their purchasing patterns. These shopping patterns allow marketing teams and product developers to gauge consumer readiness for the next innovation.

May 30, 2013

While the passage of the Patient Protection and Affordable Care Act of 2010 was a milestone in a number of respects, it also was one of the biggest moments in the history of the generic drug industry since the 1984 passage of the Hatch-Waxman Act, which created an abbreviated regulatory approval pathway for generic pharmaceutical drugs.

While the passage of the Patient Protection and Affordable Care Act of 2010 was a milestone in a number of respects, it also was one of the biggest moments in the history of the generic drug industry since the 1984 passage of the Hatch-Waxman Act, which created an abbreviated regulatory approval pathway for generic pharmaceutical drugs.

May 29, 2013

Avion Pharmaceuticals, a specialty pharmaceutical company, recently announced the launch of Prenate Chewable, a chewable, chocolate-flavored version of the original Prenate prescription prenatal vitamin.

ATLANTA — Avion Pharmaceuticals, a specialty pharmaceutical company, recently announced the launch of Prenate Chewable, a chewable, chocolate-flavored version of the original Prenate prescription prenatal vitamin.

May 29, 2013

The National Association of Specialty Pharmacy announced that CARE Pharmacies has joined the association as a founding corporate member.

TAMPA, Fla. — The National Association of Specialty Pharmacy on Tuesday announced that CARE Pharmacies has joined the association as a founding corporate member. The founding members represent all practice areas within the industry including specialty pharmacies, pharmaceutical companies, health care services, group purchasing organizations and manufacturers.  

May 28, 2013

Armada Health Care, a specialty pharmacy channel management organization, announced that the organization has been awarded Health Call Center, Health Web Site and Health Content Provider accreditation from URAC, a Washington, D.C.-based healthcare accrediting organization that establishes quality standards for the healthcare industry.

FLORHAM PARK, N.J. — Armada Health Care, a specialty pharmacy channel management organization, announced that the organization has been awarded Health Call Center, Health Web Site and Health Content Provider accreditation from URAC, a Washington, D.C.-based healthcare accrediting organization that establishes quality standards for the healthcare industry.

May 17, 2013

Alliance Boots posted a double-digit adjusted profit gain of 12.7% to $1.2 billion for its year ended March 31. Almost half of that profit is staked by Walgreens with its 45% share of the European pharmaceutical distributing powerhouse.

A couple days later, Alliance Boots along with Walgreens and AmerisourceBergen announced the necessary regulatory clearances on that strategic partnership, cementing the three companies in place as the largest generic pharmaceutical acquisition company in the world. That deal will further enable the company's to realize greater profit margins.

Alliance Boots posted a double-digit adjusted profit gain of 12.7% to $1.2 billion for its year ended March 31. Almost half of that profit is staked by Walgreens with its 45% share of the European pharmaceutical distributing powerhouse. 

May 15, 2013

A federal drug track-and-trace bill has made it out of a congressional committee.

ARLINGTON, Va. — A federal drug track-and-trace bill has made it out of a congressional committee.

The House Energy and Commerce Committee voted to approve H.R. 1919, the Safeguarding America's Pharmaceuticals Act of 2013, sponsored by Reps. Bob Latta, R-Ohio, and Jim Matheson, D-Utah.

May 14, 2013

Americans and their health care plans are spending less on medicines and health services. Is that a good thing?

Americans and their healthcare plans are spending less on medicines and health services. Is that a good thing?

Researchers for the IMS Institute for Healthcare Informatics posed that question with the release of a report on the U.S. pharmaceutical market this week. But pharmacy leaders, independent and chain pharmacists, the U.S. health system and healthcare advocates are going to be dealing with the implications of that trend going forward.

May 9, 2013

Success in the mass market can be an uphill battle for some niche brands as retailers trim selection, bolster private-label offerings and pass on smaller brands they perceive as higher risk. However, retailers also are increasingly looking to distinguish themselves from the competition, whether it is through exclusive offerings, customization or in-store services.

Success in the mass market can be an uphill battle for some niche brands as retailers trim selection, bolster private-label offerings and pass on smaller brands they perceive as higher risk. However, retailers also are increasingly looking to distinguish themselves from the competition, whether it is through exclusive offerings, customization or in-store services. This has given rise to the importance of business development organizations, master brokers, regional brokers, and sales and marketing consultants in helping niche brands navigate the path to retail.

May 8, 2013

Drug maker Bristol-Myers Squibb foresees significant effects on its business from the Patient Protection and Affordable Care Act, company executives told attendees of its recent shareholder meeting.

WASHINGTON — Drug maker Bristol-Myers Squibb foresees significant effects on its business from the Patient Protection and Affordable Care Act, company executives told attendees of the its recent shareholder meeting.

May 8, 2013

There is as much as $10 billion in branded pharmaceutical sales that could make the switch from prescription-only to over-the counter in the next five years, suggested Joseph Papa, Perrigo chairman, CEO and president, to analysts on Tuesday.

ALLEGAN, Mich. — There is as much as $10 billion in branded pharmaceutical sales that could make the switch from prescription-only to over-the counter in the next five years, suggested Joseph Papa, Perrigo chairman, CEO and president, to analysts on Tuesday. And as much as $5 billion in the next three years. 

May 3, 2013

Ohio pharmaceutical company Prasco will host the National Christian College Athletic Association championships at Prasco Park in Mason, Ohio, in May, the company announced today.

MASON, Ohio — Ohio pharmaceutical company Prasco will host the National Christian College Athletic Association championships here at Prasco Park in May, the company announced today.

College teams from all over the country will descend on Prasco Park to compete in its Division World Series May 8 to 11, and May 15 to 18.

May 2, 2013

Cardinal Health reported fiscal year 2013 third-quarter revenue of $24.6 billion, a 8.9% decline as compared to the quarter a year ago.

DUBLIN, Ohio — Cardinal Health on Thursday reported fiscal year 2013 third-quarter revenue of $24.6 billion, a 8.9% decline as compared with the quarter a year ago. 

However, Cardinal Health reported net earnings per share of $1.01, up 5.2%. According to published reports, Wall Street had been expecting greater revenue of $24.7 billion but at a lesser gain with earnings expectations estimated around 96 cents per share. 

April 26, 2013

Medical products manufacturer Covidien's pharmaceutical division is expanding an initiative to collect unused and unwanted medications.

ST. LOUIS — Medical products manufacturer Covidien's pharmaceutical division is expanding an initiative to collect unused and unwanted medications.

Mallinckrodt said it would expand communities' access to drug take-back collection boxes and promote safe disposal practices, installing lock boxes in three police stations around St. Louis. The company said it purchased the boxes under a collaboration with the National Association of Drug Diversion Investigators and also would provide a grant to help incinerate the medications that are collected.

April 26, 2013

Cardinal Health announced the renewal of its pharmaceutical distribution agreement with CVS Caremark to supply pharmaceuticals to the company’s retail pharmacies and distribution centers, as McKesson, which generally serves the PBM side of the business, also announced the renewal of its current distribution agreement with the pharmacy retailer.

The renewal of the agreements was not only critical for both companies but, as Adam Fein, president of Pembroke Consulting and CEO of Drug Channels Institute, wrote in his blog “CVS Caremark Renews with Cardinal and McKesson,” it also “demonstrates wholesalers' value in the brand-name pharmacy supply chain.”

Cardinal Health announced the renewal of its pharmaceutical distribution agreement with CVS Caremark to supply pharmaceuticals to the company’s retail pharmacies and distribution centers, as McKesson, which generally serves the PBM side of the business, also announced the renewal of its current distribution agreement with the pharmacy retailer.

April 26, 2013

A House Subcommittee on Health hearing Thursday focused on efforts to strengthen the country's pharmaceutical supply chain, and particularly on draft legislation meant to accomplish that.

While often touted as the safest in the world, the U.S. drug supply chain remains vulnerable to counterfeit, adulterated and stolen medications. Given the potentially dangerous risks of using such medicines, it is imperative that they be kept out.

A House Subcommittee on Health hearing Thursday focused on efforts to strengthen the country's pharmaceutical supply chain, and particularly on draft legislation meant to accomplish that.

While often touted as the safest in the world, the U.S. drug supply chain remains vulnerable to counterfeit, adulterated and stolen medications. Given the potentially dangerous risks of using such medicines, it is imperative that they be kept out.

April 25, 2013

Cardinal Health and McKesson separately announced the renewal of their pharmaceutical distribution agreements with CVS Caremark.

DUBLIN, Ohio — Cardinal Health and McKesson separately announced the renewal of their pharmaceutical distribution agreements with CVS Caremark.

Under Cardinal Health’s renewed agreement, the wholesaler stated that it will supply pharmaceuticals to a network of CVS Caremark's retail pharmacies and distribution centers through mid-2016. The stores and distribution centers serviced under the new arrangement are essentially the same as those serviced in the prior arrangement.

April 25, 2013

Galderma, whose brands include Cetaphil, and The American Academy of Dermatology have announced the creation of the American Academy of Dermatology Translational Biotechnology Fellowship.

CHAUMBURG, Ill., and SOPHIA ANTIPOLIS, France — Galderma, whose brands include Cetaphil, and The American Academy of Dermatology have announced the creation of the American Academy of Dermatology Translational Biotechnology Fellowship.

April 25, 2013

The House Committee on Energy and Commerce Subcommittee on Health heard testimony on Thursday morning from representatives of the Food and Drug Administration and several industry trade groups following the introduction of draft legislation that sponsors said would strengthen the country's pharmaceutical supply chain.

WASHINGTON — The House Committee on Energy and Commerce Subcommittee on Health heard testimony on Thursday morning from representatives of the Food and Drug Administration and several industry trade groups following the introduction of draft legislation that sponsors said would strengthen the country's pharmaceutical supply chain.

April 23, 2013

The Food and Drug Administration has approved a second product in BD's new line of injectable drugs, the company said Tuesday.

FRANKLIN LAKES, N.J. — The Food and Drug Administration has approved a second product in BD's new line of injectable drugs, the company said Tuesday.

BD Rx, the pharmaceutical arm of the medical technology manufacturer, whose name stands for Becton, Dickinson and Co., received FDA approval for metoclopramide, part of its BD Simplist line of ready-to-administer pre-filled generic injectables. The product is an antiemetic, a drug used to stop vomiting.